Nunoi K, Satho Y, Tsutsu N, Iwase M, Wakisaka M, Fujishima M
Second Department of Internal Medicine, Kyushu University, Fukuoka, Japan.
J Diabet Complications. 1991 Apr-Sep;5(2-3):176-8. doi: 10.1016/0891-6632(91)90064-v.
The protective effect of phosphate binder (PB) on nephropathy was examined in spontaneously hypertensive rats with non-insulin-dependent diabetes mellitus (NIDDM) fed a high-protein diet. The rats were treated with vehicle or streptozocin neonatally. After 14 weeks, all rats were fed a high-protein diet (50% protein content), and in half of the diabetic rats the diets were supplemented with PB. At 24 weeks, the urinary excretion rate of albumin and kidney weight increased in diabetic rats, but decreased or tended to decrease in diabetic rats treated with PB. The elevation of urinary excretion rate of N-acetyl-beta-D-glucosaminidase, probably due to protein load, was also abolished with PB.
在喂食高蛋白饮食的非胰岛素依赖型糖尿病(NIDDM)自发性高血压大鼠中,研究了磷酸盐结合剂(PB)对肾病的保护作用。大鼠在新生期用载体或链脲佐菌素处理。14周后,所有大鼠均喂食高蛋白饮食(蛋白质含量50%),且一半糖尿病大鼠的饮食中补充了PB。24周时,糖尿病大鼠的白蛋白尿排泄率和肾脏重量增加,但在接受PB治疗的糖尿病大鼠中降低或趋于降低。PB还消除了可能由于蛋白质负荷导致的N-乙酰-β-D-氨基葡萄糖苷酶尿排泄率升高。